To investigate the contribution of glycation and oxidation reactions to the modification of insoluble collagen in aging and diabetes, Maillard reaction products were measured in skin collagen from 39 type 1 diabetic patients and 52 nondiabetic control subjects. Compounds studied included fructoselysine (FL), the initial glycation product, and the glycoxidation products, N epsilon-(carboxymethyl) lysine (CML) and pentosidine, formed during later Maillard reactions. Collagen-linked fluorescence was also studied. In nondiabetic subjects, glycation of collagen (FL content) increased only 33% between 20 and 85 yr of age. In contrast, CML, pentosidine and fluorescence increased five-fold, correlating strongly with age. In diabetic patients, collagen FL was increased threefold compared with nondiabetic subjects, correlating strongly with glycated hemoglobin but not with age. Collagen CML, pentosidine and fluorescence were increased up to twofold in diabetic compared with control patients: this could be explained by the increase in glycation alone, without invoking increased oxidative stress. There were strong correlations among CML, pentosidine and fluorescence in both groups, providing evidence for age-dependent chemical modification of collagen via the Maillard reaction, and acceleration of this process in diabetes. These results support the description of diabetes as a disease characterized by accelerated chemical aging of long-lived tissue proteins.
D G Dyer, J A Dunn, S R Thorpe, K E Bailie, T J Lyons, D R McCance, J W Baynes
Title and authors | Publication | Year |
---|---|---|
Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets
H Farhangkhoee, ZA Khan, H Kaur, X Xin, S Chen, S Chakrabarti |
Pharmacology & Therapeutics | 2005 |
The Receptor for Advanced Glycation End Products Is Highly Expressed in the Skin and Upregulated by Advanced Glycation End Products and Tumor Necrosis Factor-Alpha
C Lohwasser, D Neureiter, B Weigle, T Kirchner, D Schuppan |
Journal of Investigative Dermatology | 2005 |
The Receptor for Advanced Glycation End Products Is Highly Expressed in the Skin and Upregulated by AGE and Tumor Necrosis Factor-alpha
C Lohwasser, D Neureiter, B Weigle, T Kirchner, D Schuppan |
Journal of Investigative Dermatology | 2005 |
A Lethal Tetrad in Diabetes: Hyperglycemia, Dyslipidemia, Oxidative Stress, and Endothelial Dysfunction
Y Yu, TJ Lyons |
The American Journal of the Medical Sciences | 2005 |
Migration of keratinocytes is impaired on glycated collagen I
K Morita, K Urabe, Y Moroi, T Koga, R Nagai, S Horiuchi, M Furue |
Wound Repair and Regeneration | 2005 |
Oxidative stress and uremia
F Floccari, C Aloisi, E Crascì, T Sofi, S Campo, D Tripodo, M Criseo, N Frisina, M Buemi |
Medicinal Research Reviews | 2005 |
Structure of the tetrameric form of human L-Xylulose reductase: Probing the inhibitor-binding site with molecular modeling and site-directed mutagenesis
O El-Kabbani, V Carbone, C Darmanin, S Ishikura, A Hara |
Proteins: Structure, Function, and Bioinformatics | 2005 |
Structure-based discovery of human l-xylulose reductase inhibitors from database screening and molecular docking
V Carbone, S Ishikura, A Hara, O El-Kabbani |
Bioorganic & Medicinal Chemistry | 2005 |
Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats
N Ashokkumar, L Pari |
Clinica Chimica Acta | 2005 |
Rapid and simple method for determination of Nɛ-(carboxymethyl)lysine and Nɛ-(carboxyethyl)lysine in urine using gas chromatography[sol ]mass spectrometry
R Petrovič, J Futas, J Chandoga, V Jakuš |
Biomedical Chromatography | 2005 |
Advanced Glycation End Products and Diabetic Nephropathy
MC Thomas, JM Forbes, ME Cooper |
American Journal of Therapeutics | 2005 |
Synthesis, tandem MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced glycation endproduct, 6-N-carboxymethyllysine
T Delatour, F Fenaille, V Parisod, FA Vera, T Buetler |
Amino Acids | 2005 |
Niacinamide: A B Vitamin that Improves Aging Facial Skin Appearance
DL Bissett, JE Oblong, CA Berge |
Dermatologic Surgery | 2005 |
Advanced glycation endproducts—role in pathology of diabetic complications
N Ahmed |
Diabetes Research and Clinical Practice | 2005 |
Advanced Glycation End Products and Diabetic Nephropathy:
MC Thomas, JM Forbes, ME Cooper |
American Journal of Therapeutics | 2005 |
Capillary electrophoretic analysis of advanced glycation endproducts formed from the reaction of reducing sugars with the amino group of glucosamine
U Dutta, JA Dain |
Analytical Biochemistry | 2005 |
Cross-Linking of the Extracellular Matrix by the Maillard Reaction in Aging and Diabetes: An Update on “a Puzzle Nearing Resolution”
VM Monnier, GT Mustata, KL Biemel, O Reihl, MO Lederer, D Zhenyu, DR Sell |
Annals of the New York Academy of Sciences | 2005 |
Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal Disease
JW Hartog, AP de Vries, HL Lutgers, R Meerwaldt, RM Huisman, WJ van Son, PE de Jong, AJ Smit |
Annals of the New York Academy of Sciences | 2005 |
Tissue-Specific Variation in Glycation of Proteins in Diabetes: Evidence for a Functional Role of Amadoriase Enzymes
SM Brown, DM Smith, N Alt, SR Thorpe, JW Baynes |
Annals of the New York Academy of Sciences | 2005 |
Advanced glycation end products and the kidney
JM Bohlender, S Franke, G Stein, G Wolf |
American journal of physiology. Renal physiology | 2005 |
Dermatoses em pacientes com diabetes mellitus
NT Foss, DP Polon, MH Takada, MC Foss-Freitas, MC Foss |
Revista de Saúde Pública | 2005 |